Stockscreener 앱 받기
2.22
0.45%
-0.010
전일 마감가:
$2.23
열려 있는:
$2.1332
하루 거래량:
2,269
Relative Volume:
0.14
시가총액:
$15.58M
수익:
$1.34M
순이익/손실:
$-13.49M
주가수익비율:
-0.1789
EPS:
-12.4093
순현금흐름:
$-3.07M
1주 성능:
+0.68%
1개월 성능:
+2.30%
6개월 성능:
-28.39%
1년 성능:
-71.47%
1일 변동 폭
$2.1332
$2.229
1주일 범위
$2.13
$2.2699
52주 변동 폭
$1.75
$9.56
Vyome Holdings Inc Stock (HIND) Company Profile
명칭
Vyome Holdings Inc
전화
949-429-6680
주소
1001 CALLE AMANECER, SAN CLEMENTE
Compare HIND vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIND
Vyome Holdings Inc
|
2.22 | 16.00M | 1.34M | -13.49M | -3.07M | -12.41 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vyome Holdings Inc 주식(HIND)의 최신 뉴스
Vyome Holdings, Inc. (NASDAQ: HIND) Share Price, HIND Stock News, HIND Share Price & Updates - Kalkine
Vyome (HIND) Move: Records a 1.77% Increase to $2.31 on the Day; the Near-Term Reference Band Stretches From $2.19 to $2.43 in the Current UpdateSuperTrend - vinanet.vn
HIND Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 48.4% EPS BeatForward EPS Estimate - vinanet.vn
VYOME HOLDINGS ($HIND) Releases Q2 2026 Earnings - Quiver Quantitative
Vyome Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vyome Holdings (HIND) Edges Lower: Stock Testing Support Near $2.11KAMA Signal - Vinanet
Vyome Holdings (HIND) posts higher H1 2026 loss as R&D spending grows - Stock Titan
Vyome Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Vyome net loss widens to $719,683 in Q2 FY26; revenue falls to $26,955 - Bitget
Vyome Holdings Ord Shs (HIND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vyome Holdings Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
HIND Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SentimentEPS Surprise History - vinanet.vn
HIND Q2'26 Earnings: EPS estimate is (0.19) USD - TradingView
Vyome Holdings, Inc. Revenue Breakdown – NASDAQ:HIND - TradingView
Vyome Holdings (HIND) Slides 2.37%: Support and Resistance Levels in FocusSafe Entry Stocks - dars.gov.et
HIND|Vyome Holdings Ord Shs|Price:2.060|Chg%:-0.080 - TradingKey
HIND|Vyome Holdings Ord Shs|Price:1.990|Chg%:-0.010 - TradingKey
Vyome Holdings (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesWeak Earnings Momentum - vinanet.vn
HIND Q1 2026 Earnings: Bottom-Line Beat Drives Sentiment Amid Absence of Revenue DetailsEarnings Decline Risk - vinanet.vn
Price to sales forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
HIND Q1 2026 Earnings: EPS Beat Estimates as Cost Management Drives SurpriseEarnings Analysis - vinanet.vn
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrower Loss Beats Expectations Amid Weak Revenue DisclosureCFO Commentary Report - dars.gov.et
HIND Q1 2026 Earnings: Positive EPS Surprise Fails to Lift Shares Amid Revenue Uncertainty - vinanet.vn
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: EPS Beat Cuts Losses, but Stock Slides on Revenue AbsenceLong-Term Guidance - dars.gov.et
Vyome (HIND) Proxy Filing Summary - Quartr
Vyome Holdings (HIND) Edges Lower Amid Consolidation Near Key SupportNegative Gamma - dars.gov.et
Vyome (HIND) Proxy filing Summary - Quartr
Vyome (HIND) Q4 2025 earnings summary - Quartr
Vyome (HIND) Q3 2025 earnings summary - Quartr
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrowing Losses Boost Investor ConfidenceRevenue Beat Analysis - dars.gov.et
Vyome Holdings (HIND) Slides 3.2% as Shares Test Key Support ZoneValue ETF - dars.gov.et
HIND Q1 2026 Earnings: Surprise EPS Beat Amidst No Revenue, Stock DeclinesEarnings Season Outlook - po-news-eg.net
Price to book forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: EPS Surprise Beats Street EstimatesEPS Consistency Score - dars.gov.et
HIND Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherEPS Miss Report - DonanımHaber
Enterprise value to EBITDA forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome receives Chinese patent for acne treatment formulation - Investing.com
Vyome receives Chinese patent for acne treatment formulation By Investing.com - Investing.com Canada
Enterprise value to revenue forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Number of shareholders of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView
Vyome Holdings, Inc. Actuals & Estimates (NASDAQ:HIND) - TradingView
HIND Forecast — Price Target — Prediction for 2027 - TradingView
Vyome Holdings Inc. (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift StockEPS Consistency Score - dars.gov.et
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN
HIND Q1 2026 Earnings: EPS Surprises Positive as Cost Control Takes Center StageAnalyst Earnings Estimate - newsline.com
HIND Q1 2026 Earnings: EPS Surprises with 18.3% Beat Amid Revenue UncertaintyFiscal Year Earnings - newsline.com
Vyome Holdings (HIND) Declines 3.65% as Stock Tests Key Support ZoneIntraday Trade Ideas - dars.gov.et
HIND Q1 2026 Earnings: EPS Beats Estimates as Losses Narrow; Stock RisesCFO Commentary Report - newsline.com
Vyome to present VT-1953 Phase 2 data at cancer research meeting - Investing.com
Earnings call transcript: Vyome Holdings Q1 2026 shows strong cash position - Investing.com
HIND Q1 2026 Earnings: EPS Beats Estimates as Development Pipeline AdvancesSurprise Factor Analysis - The Legal Advocate
Vyome Holdings Inc (HIND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):